Aripiprazole and Micardis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Micardis (telmisartan). Common drug interactions include malaise among females and schizophrenia among males.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Micardis. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

On Jul, 26, 2026

26 people who take Aripiprazole and Micardis together, and have interactions are studied.

Aripiprazole and Micardis drug interactions.

What are the common drug interactions of Aripiprazole and Micardis, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Cataract (clouding of the lens inside the eye)
White blood cell count increased
Ataxia (loss of full control of bodily movements)
Cough
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Dependent personality disorder
Disturbance in attention
Eye infection

male:

Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Injection site erythema (redness at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Irritability
Persecutory delusion
Polydipsia (excessive thirst)

What are the common drug interactions of Aripiprazole and Micardis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood lactic acid increased
Dizziness
Dyspnoea (difficult or laboured respiration)
Hypertensive heart disease
Malaise (a feeling of general discomfort or uneasiness)
Anxiety disorder
Back pain
Sleep disorder

50-59:

Ataxia (loss of full control of bodily movements)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Malaise (a feeling of general discomfort or uneasiness)
Dependent personality disorder
Disturbance in attention
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Memory impairment
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Injection site erythema (redness at injection site)

60+:

Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Cataract (clouding of the lens inside the eye)
Hypersensitivity
Asthenia (weakness)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Infusion site discomfort
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Irritability
Pain
Persecutory delusion

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 12 people, 46.15%
Stiff Person Syndrome: 5 people, 19.23%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 5 people, 19.23%
Diabetes: 3 people, 11.54%
Urinary Tract Infection: 2 people, 7.69%
Type 2 Diabetes: 2 people, 7.69%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 7.69%
Insulin Resistant Diabetes: 2 people, 7.69%
Insomnia (sleeplessness): 2 people, 7.69%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Micardis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously